Dark | Light
[GUEST ACCESS MODE: Data is scrambled or limited to provide examples. Make requests using your API key to unlock full data. Check https://lunarcrush.ai/auth for authentication information.]

![AIStockSavvy Avatar](https://lunarcrush.com/gi/w:24/cr:twitter::72858967.png) Hardik Shah [@AIStockSavvy](/creator/twitter/AIStockSavvy) on x 17.3K followers
Created: 2025-07-14 13:15:45 UTC

$PROK | 𝐏𝐫𝐨𝐊𝐢𝐝𝐧𝐞𝐲 (PROK): Guggenheim reiterates 𝐁𝐮𝐲, raises 𝐏𝐓 𝐭𝐨 $𝟕 (𝐟𝐫𝐨𝐦 $𝟔)

Analyst boosts confidence in 𝐫𝐢𝐥𝐩𝐚𝐫𝐞𝐧𝐜𝐞𝐥'𝐬 𝐩𝐨𝐭𝐞𝐧𝐭𝐢𝐚𝐥, citing 𝐜𝐥𝐢𝐧𝐢𝐜𝐚𝐥𝐥𝐲 𝐦𝐞𝐚𝐧𝐢𝐧𝐠𝐟𝐮𝐥 𝐞𝐆𝐅𝐑 𝐢𝐦𝐩𝐚𝐜𝐭 and rising expert enthusiasm ahead of key FDA and ASN updates.

![](https://pbs.twimg.com/media/Gv0hrESW4AAwflw.jpg)

XXXXX engagements

![Engagements Line Chart](https://lunarcrush.com/gi/w:600/p:tweet::1944747648004575441/c:line.svg)

**Related Topics**
[asn](/topic/asn)
[$prok](/topic/$prok)

[Post Link](https://x.com/AIStockSavvy/status/1944747648004575441)

[GUEST ACCESS MODE: Data is scrambled or limited to provide examples. Make requests using your API key to unlock full data. Check https://lunarcrush.ai/auth for authentication information.]

AIStockSavvy Avatar Hardik Shah @AIStockSavvy on x 17.3K followers Created: 2025-07-14 13:15:45 UTC

$PROK | 𝐏𝐫𝐨𝐊𝐢𝐝𝐧𝐞𝐲 (PROK): Guggenheim reiterates 𝐁𝐮𝐲, raises 𝐏𝐓 𝐭𝐨 $𝟕 (𝐟𝐫𝐨𝐦 $𝟔)

Analyst boosts confidence in 𝐫𝐢𝐥𝐩𝐚𝐫𝐞𝐧𝐜𝐞𝐥'𝐬 𝐩𝐨𝐭𝐞𝐧𝐭𝐢𝐚𝐥, citing 𝐜𝐥𝐢𝐧𝐢𝐜𝐚𝐥𝐥𝐲 𝐦𝐞𝐚𝐧𝐢𝐧𝐠𝐟𝐮𝐥 𝐞𝐆𝐅𝐑 𝐢𝐦𝐩𝐚𝐜𝐭 and rising expert enthusiasm ahead of key FDA and ASN updates.

XXXXX engagements

Engagements Line Chart

Related Topics asn $prok

Post Link

post/tweet::1944747648004575441
/post/tweet::1944747648004575441